Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHZ2100598	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	License Renew	2021-08-09					view
JYHZ2100597	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	License Renew	2021-08-09					view
JYHZ2100596	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	License Renew	2021-08-09					view
JYHB2400077	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2024-02-07					view
JYHB2400076	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2024-02-07					view
JYHB2400075	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2024-02-07					view
JYHB2200556	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-10-13					view
JYHB2200555	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-10-13					view
JYHB2200554	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-10-13					view
JYHB2200486	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-09-05					view
JYHB2200485	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-09-05					view
JYHB2200484	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2022-09-05					view
JYHB2002755	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2021-01-01	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2021-03-22	view
JYHB2002754	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2021-01-01	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Approval Completed-Pending Certificated	2021-10-25	view
JYHB2002753	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2021-01-01	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2021-03-22	view
JYHB2001550	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2020-08-24	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-17	view
JYHB2001549	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2020-08-24	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-17	view
JYHB2001548	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2020-08-24	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Certificate Issued	2020-11-17	view
JYHB2000897	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2020-06-19	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-06-24	view
JYHB2000349	磷酸芦可替尼片	ruxolitinib phosphate	Tablet	Chemical Drugs	Supplementary Application	2020-03-30	Novartis Pharma Schweiz AG	Novartis Pharma Schweiz AG	Filed	2020-04-13	view